INDEPENDENT DEAL STRATEGY

Is your biggest deal actually as healthy as your CRM says it is?

Independent deal reviews for complex B2B sales opportunities — identifying qualification gaps, stakeholder risk and the actions most likely to move the deal forward.

Assess My Deal Request a Deal Review

Built around practical MEDDIC principles and more than two decades of enterprise sales experience.

ENTERPRISE DEAL SCORE™LIVE

72/ 100

DEAL HEALTH

MEDDIC

BUYER ACCESS

EVIDENCE

Key riskDecision process not yet evidenced.

WHY LARGE DEALS STALL

Hard work isn't the same as deal health.

Complex opportunities rarely fail because the salesperson didn't care. They fail because something important was assumed rather than proven.

01No genuine champion

Someone likes the solution, but nobody is selling internally.

02Economic buyer unknown

The buying committee is mapped, but authority isn't.

03Decision process assumed

The close date is known. The path to the close isn't.

04Forecast built on optimism

“90%” confidence is based on sentiment rather than evidence.

05Procurement appears late

Commercial and legal steps arrive as surprises.

06Competition underestimated

“Do nothing” is forgotten as a competitor.

THE FRAMEWORK

Turn deal intuition into evidence.

Enterprise Deal Lab combines practical MEDDIC thinking with a simple evidence-based scoring model. The goal isn't a pretty methodology slide. It's a clearer view of what you know, what you're assuming and what needs to happen next.

Try the 20-point scorecard →

maximum evidence points

20 questions scored from unknown to confirmed.

THREE WAYS TO USE THE LAB